Previous 10 | Next 10 |
The shares of Evofem Biosciences (WVFM), a biopharma focused on women’s sexual and reproductive health gained in the pre-market Tuesday on above average volume after the company announced a peer reviewed publication of an article on its Phexxi birth control method. More tha...
Phexxi® Mechanism of Action Article Published in the Journal of Therapeutic Advances in Reproductive Health PR Newswire SAN DIEGO , July 12, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) announced today that the Journal of ...
Buying Penny Stocks on July 12th? Here’s What You Need to Know If you’re thinking about buying penny stocks right now, there is a lot for investors to know. As a result of the high level of volatility in the stock market, investors are working to find penny stocks that...
Agile Therapeutics ( NASDAQ: AGRX ) rose sharply in the early trading on Monday after H.C. Wainwright doubled the price target on the women's healthcare company to a Street high of $5.00 citing its prospects following the recent Supreme Court ruling on abortion rights. ...
3 Penny Stocks to Add to Your Watchlist Right Now With another interesting day of trading for penny stocks and blue chips, there is a lot for investors to know right now. Today, the stock market is seeing bullish trading patterns with the S&P 500 up by over 1.4% at midday and the NA...
Today, we take a deeper look at a birth control biopharma concern called Evofem Biosciences, Inc. whose shares have plummeted to a buck a piece. Its flagship product Phexxi is seeing impressive revenue growth and has seen some positive news flow of late as well. An investment anal...
Gainers: Inspira Technologies ( IINN ) +75% . Resolute Forest Products ( RFP ) +64% . Shattuck Labs ( STTK ) +23% . Omega Therapeutics ( OMGA ) +23% . Evofem Biosciences ( EVFM ) +23% . Zevia ( ZVIA ) +21% . Eos E...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: motorolka / Shutterstock.com Evofem Biosciences (NASDAQ: EVFM ) stock only recently became well-known on Wall Street. After the U.S. Supreme Court overturned Roe vs. Wade, the rush on contraceptives propel...
Evofem Biosciences focuses on women's sexual and reproductive health and recently developed Phexxi, a non-hormonal female contraceptive. CEO Saundra Pelletier discusses investing implications of the Roe v Wade reversal. Breaking down EVFM’s strong growth rating despite poor...
3 Tips for Buying Penny Stocks in July 2022 When it comes to buying penny stocks, there are a few things you should know in order to make the most informed decision possible. The most crucial aspect when it comes to trading penny stocks is to know what you’re buying. Itȁ...
News, Short Squeeze, Breakout and More Instantly...
Evofem Biosciences Inc. Company Name:
EVFM Stock Symbol:
NASDAQ Market:
Evofem Biosciences Inc. Website:
Aditxt (NASDAQ: ADTX) , a company dedicated to discovering, developing and deploying promising health innovations, along with its wholly owned subsidiary Adifem Inc., and Evofem Biosciences Inc. (OTCQB: EVFM) have amended and restated their previously announced merger agreement. Accor...
Evofem Acquires SOLOSEC, an FDA-Approved Single-Dose Treatment for Bacterial Vaginosis and Trichomoniasis Aditxt, Inc. (“Aditxt”) (NASDAQ: ADTX), a company dedicated to discovering, developing, and deploying promising health innovations, announces this past Friday, July 12...
2024-06-27 10:57:17 ET This company is striving to change the narratives around women's healthcare and offering solutions that reinforce and improve them. And shares are responding positively to a recent partnership announcement. Women's health innovator %EvofemBiosciences Inc. (OTC...